title: Pneumothorax and wound dehiscence related to collagenase deregulation: treatment with diphenylhydantoin.
abstract: BACKGROUND
  Wound dehiscence is an uncommon complication of operation, usually related to a recognized risk factor. A clinical dilemma arises when dehiscence has no identifiable cause or treatment.
  
  
  METHODS
  We describe the case of a previously healthy 45-year-old man in whom recurrent spontaneous pneumothoraces developed followed by multiple dehiscences of thoracotomy, diaphragmatic, and abdominal wounds. Analysis over several years of laboratory investigation of cultured tissue from test incisions was initially unsuccessful. The patient was supported symptomatically until a remarkable laboratory finding enabled us to develop an effective treatment plan.
  
  
  RESULTS
  Cultured patient fibroblasts were ultimately found to express abnormally elevated levels of collagenase, which could be inhibited by diphenylhydantoin (phenytoin) in vitro. Treatment of the patient with a course of diphenylhydantoin allowed adequate healing of test incisions and subsequent definitive surgical treatment with successful wound healing.
  
  
  CONCLUSIONS
  This report of the rigorous application of the scientific method to the investigation and treatment of an enigmatic case of wound dehiscence might serve as a guide to surgeons faced with similar healing problems.
authors.affiliation: Department of Surgery, Albany Medical College, New York, USA.
authors.forename: M J
authors.initials: MJ
authors.lastname: O'Toole
authors.forename: J E
authors.initials: JE
authors.lastname: Kolb
authors.forename: W J
authors.initials: WJ
authors.lastname: Lindblad
authors.forename: I K
authors.initials: IK
authors.lastname: Cohen
authors.forename: M F
authors.initials: MF
authors.lastname: McKneally
mesh_terms: D000005:Abdomen / Q000601:surgery; D017364:Collagenases / Q000378:metabolism*; D003964:Diaphragm / Q000601:surgery; D005347:Fibroblasts / Q000201:enzymology; D006801:Humans; D008297:Male; D061965:Matrix Metalloproteinase Inhibitors; D008659:Metabolic Diseases / Q000150:complications / Q000188:drug therapy; D008875:Middle Aged; D010672:Phenytoin / Q000627:therapeutic use*; D011030:Pneumothorax / Q000209:etiology* / Q000517:prevention & control; D011480:Protease Inhibitors / Q000627:therapeutic use*; D012008:Recurrence; D012867:Skin / Q000166:cytology / Q000201:enzymology; D013529:Surgical Wound Dehiscence / Q000209:etiology* / Q000517:prevention & control; D013908:Thoracotomy / Q000009:adverse effects; D014945:Wound Healing
chemical_list: D061965:Matrix Metalloproteinase Inhibitors; D011480:Protease Inhibitors; D010672:Phenytoin; D017364:Collagenases